Physician profile
Aisha Simjee
NPI 1659335156
$3,058.02
in general payments reported to CMS, 2019-2025
24 companies · $499 in 2025
The $499 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $47.92 · 2021: $447 · 2022: $449 · 2023: $597 · 2024: $539 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,635.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $345.08 | 2019-2025 | Rocklatan, Simbrinza, Rhopressa |
| Abbvie INC. | $314.86 | 2022-2025 | Lumigan, Durysta |
| Sun Pharmaceutical Industries INC. | $214.95 | 2021-2025 | |
| Bausch & Lomb Americas INC. | $196.93 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Allergan, INC. | $184.00 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $182.86 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $172.93 | 2021 | |
| Genentech USA, INC. | $149.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $142.59 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $138.38 | 2020-2022 | |
| Thea Pharma INC. | $133.18 | 2023-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $129.86 | 2022-2023 | Tyrvaya |
| Spark Therapeutics, INC. | $125.00 | 2021 | |
| Horizon Therapeutics Plc | $119.67 | 2022-2023 | Tepezza |
| New World Medical,INC. | $93.30 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $88.64 | 2024-2025 | Tepezza |
| Dompe US, INC. | $83.79 | 2024-2025 | Oxervate |
| Shire North American Group INC | $83.50 | 2019 | |
| Sight Sciences, INC. | $38.23 | 2021-2023 | Omni Surgical System |
| Eyevance Pharmaceuticals LLC | $33.11 | 2022 | |
| Rxsight INC | $26.54 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Akorn, INC. | $24.23 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.00 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Simjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.